Severity prediction rules in community acquired pneumonia: a validation study
about
Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation studyStudy of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelinesIs COPD associated with increased mortality and morbidity in hospitalized pneumonia? A systematic review and meta-analysisTools for outcome prediction in patients with community acquired pneumonia.Quantitative analysis of lung ultrasonography for the detection of community-acquired pneumonia: a pilot study.Prevalence and Prognostic Significance of Hyponatremia in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Data from the Akershus Cardiac Examination (ACE) 2 Study.Long-term prognosis in community-acquired pneumonia.Effects of inhaled corticosteroids on pneumonia severity and antimicrobial resistance.Defining and predicting severe community-acquired pneumonia.Community-acquired pneumonia in elderly patients.Radiological-pathological correlation: alveolar pattern.Pneumonia and pregnancy.Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality.An evaluation of the discriminant and predictive validity of relative social disadvantage as screening criteria for priority access to public general dental care, in Australia.Defining severe pneumonia.Studying the burden of community-acquired pneumonia in adults aged ≥50 years in primary health care: an observational study in rural Crete, Greece.Risk of pneumonia in patients taking statins: population-based nested case-control study.A national confidential enquiry into community acquired pneumonia deaths in young adults in England and Wales. British Thoracic Society Research Committee and Public Health Laboratory ServiceValidation of predictive rules and indices of severity for community acquired pneumoniaOptimizing treatment outcomes in severe community-acquired pneumonia.Pneumococcal lower respiratory tract infections in adults: an observational case-control study in primary care in Belgium.Illness behaviour and antibiotic prescription in patients with respiratory tract symptoms.A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumoniaThe CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia.Hypocapnia and hypercapnia are predictors for ICU admission and mortality in hospitalized patients with community-acquired pneumonia.Healthcare-associated Pneumonia: Clinical Features and Retrospective Analysis Over 10 Years.Clinical Usefulness of Urinary Fatty Acid Binding Proteins in Assessing the Severity and Predicting Treatment Response of Pneumonia in Critically Ill Patients: A Cross-Sectional Study.Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia.External validation of the CURSI criteria (confusion, urea, respiratory rate and shock index) in adults hospitalised for community-acquired pneumonia.Predicting mortality among older adults hospitalized for community-acquired pneumonia: an enhanced confusion, urea, respiratory rate and blood pressure score compared with pneumonia severity index.Predicting ICU admission in community-acquired pneumonia: clinical scores and biomarkers.Chronic obstructive pulmonary disease and mortality from pneumonia: meta-analysis.Mortality in Patients Admitted for Concurrent COPD Exacerbation and Pneumonia.Plasma cytokines eotaxin, MIP-1α, MCP-4, and vascular endothelial growth factor in acute lower respiratory tract infection.Reappraisal of criteria used to predict serious bacterial illness in febrile infants less than 8 weeks of age.Intrapleural therapy in management of complicated parapneumonic effusions and empyema.Empyema thoracisRisk prediction models for mortality in community-acquired pneumonia: a systematic review.The usefulness of confusion, urea, respiratory rate, and shock index or adjusted shock index criteria in predicting combined mortality and/or ICU admission compared to CURB-65 in community-acquired pneumonia.Are COPD patients with pneumonia who are taking inhaled corticosteroids at higher risk of dying?
P2860
Q24678793-B6C6C793-2663-4CDE-96DE-3231463FF2F3Q24679117-E32B96C6-1C7B-4CAA-99B4-02D54CC6E048Q26801413-3A6BFA41-D772-45DA-8D20-BA6DC4EEFC6BQ30240254-FBE1C33D-0D59-4D98-9F8E-D704786175E8Q30416037-85E01E4D-EF41-4401-83B9-1FC027741901Q31121896-A2AC3444-86BA-4374-AD89-166B467438DFQ33790638-BF2C8B2D-2D81-4923-8F1F-822F0C50BF8CQ33790645-656D34AE-9E57-4D97-AE5E-55534BD4F181Q33872274-15803FC9-4F75-4DD8-855C-326CA9B04288Q34048462-1C21039E-C80A-44B6-BAF0-2997EB67106EQ34190450-AC046945-353B-4CF3-8812-A62F9003F3F0Q34225342-E0EF0B96-0659-4EC5-A506-954D0A4ECF69Q34492540-F54AB5B7-40C8-4E5F-A371-168141B1C660Q35110107-5BE27E20-64BA-4E8E-A760-762F22C6230AQ35184605-039E479B-6BA2-4A67-8397-3CC73219CBF9Q35216034-34817CBB-EC30-4C81-9240-E716A8FC0864Q35511988-698FC117-4EA9-42BE-A269-773338DAB797Q35533592-9FEEED42-D945-4D37-8ECB-5C9AD344AE04Q35536679-D1EAF479-5519-4607-B28E-3EB19969108BQ35627748-73000A66-074D-4B95-ABAD-08EAE7086F45Q35642397-3130D0F1-9304-4C88-ADA6-E933264A44A7Q36177562-C64A865C-330E-45BC-AE19-AA142BE9C004Q36203036-812B54CE-62F5-4BC2-AC82-A8BC6EF61A59Q36225617-7191A96B-0480-4856-A7E1-2FBBB819AD54Q36388035-2ECC9FE2-71C0-434C-8713-A06601B03571Q36531884-5A1F3D14-67B3-4821-8720-F1BADC5E16FDQ36993614-A656E0B3-E385-4008-A0D6-A957EF1F402AQ37440972-5B103E83-139C-47A8-A365-219ACCF1C74AQ37515038-30E9F825-42AA-4018-ACF8-434ACFBCCD09Q38009052-14E79864-B8A3-4982-BE30-22D53CBE40B9Q38040130-F42EA3EA-FE90-4965-9154-7E198999EDDCQ38097887-9501A172-0343-4147-97F4-ED4E3DA53145Q39358377-4327E472-2202-4A2B-AF87-3E3081F6674CQ40446532-DFCC9BA0-758B-4E60-BD38-8F420AF3B453Q40497202-C67054B4-AA0D-4A40-8E8B-4E9DD369DD19Q40541497-85C165E4-26B0-408A-9A73-4DC5EEC7FC4AQ41141522-398CC6A2-B5F7-4AF6-B52D-B26B93CF63F8Q41761161-99718BB5-4064-4A2B-A5E0-28E6E86929C9Q42583875-CBA2EDB4-A3B3-4A34-B4CA-EB4C9E6B6E73Q42721099-DB878F5D-891A-4A62-A14D-B22C24308390
P2860
Severity prediction rules in community acquired pneumonia: a validation study
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Severity prediction rules in community acquired pneumonia: a validation study
@ast
Severity prediction rules in community acquired pneumonia: a validation study
@en
type
label
Severity prediction rules in community acquired pneumonia: a validation study
@ast
Severity prediction rules in community acquired pneumonia: a validation study
@en
prefLabel
Severity prediction rules in community acquired pneumonia: a validation study
@ast
Severity prediction rules in community acquired pneumonia: a validation study
@en
P2093
P2860
P356
P1433
P1476
Severity prediction rules in community acquired pneumonia: a validation study
@en
P2093
P2860
P304
P356
10.1136/THORAX.55.3.219
P407
P577
2000-03-01T00:00:00Z